|
Lupin seeks biosimilar, lung drug partners
Reuters India Making copies of biotech medicines is emerging as a hot new business area for Indian pharmaceutical companies, which are seeking to move up the value curve by producing more complex and higher-margin generic products. Rival Dr.Reddy’s Laboratories … |
|
Indian stocks to watch-March 4
Reuters India … electricity – Economic Times (link.reuters.com/set37v) INTERVIEW-India’s Lupin seeks biosimilar, lung drug partners DLF again under competition watchdog’s lens – Business Standard (link.reuters.com/ret37v) IOC eyes stakes in LNG terminals at Mundra … |
Washington Post |
Diesel-powered vehicles leave New Delhi’s air worse than Beijing’s
Washington Post India subsidizes sales of the fuel to the equivalent of $15 billion a year, encouraging purchases of diesel vehicles that can pump out exhaust gases with 10 times the carcinogenic particles found in gasoline exhausts. The result: Delhi’s air on average … |
Bhargava board certified in hematologyOnline AthensShe received her medical degree from the M.S. Ramaiah Medical College in Bangalore, India. She went on to complete her residency at the … and American Society of Hematology. Her special interests inc…
|
INTERVIEW-India’s Lupin seeks biosimilar, lung drug partners
Reuters Seeks partner to develop device for lung drugs. By Zeba Siddiqui and Ben Hirschler. MUMBAI, March 3 (Reuters) – Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of … |
Economic Times |
India’s Lupin seeks biosimilar, lung drug partners
Reuters UK MUMBAI (Reuters) – Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most … Lupin seeks biosimilar, lung drug partnersReuters India |
|
India’s Lupin seeks biosimilar, lung drug partners
Reuters India MUMBAI (Reuters) – Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most … |
|
India’s Lupin seeks biosimilar, lung drug partners
Reuters MUMBAI (Reuters) – Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most … |
The New Indian ExpressInnovation IncubatorThe New Indian ExpressAfter completing his graduation from Kumaon Engineering College, Uttaranchal-born Nitin Joshi joined the premier Indian Institute of Technology-Bombay for his masters and a subsequent post…
Ambareesh recovering, says wifeTimes of IndiaAmbareesh was admitted to Vikram Hospital, Millers Road, on February 21 after he complained of difficulty in breathing and high fever. He was diagnosed with lung infection and put on ventilator. An air-ambul…